Despite decades of attention and study, racial and ethnic minority accrual to clinical trials remains poor. Serious efforts are needed to incentivize providers to enroll patients and clinical trial sponsors to target enrollment for underrepresented groups.
http://ift.tt/2hbqjTr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου